 Proportional Hazards Models
"Proportional Hazards Models" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Statistical models used in survival analysis that assert that the effect of the study factors on the hazard rate in the study population is multiplicative and does not change over time.
| Descriptor ID |
D016016
|
| MeSH Number(s) |
E05.318.740.500.700 E05.318.740.600.700 E05.318.740.750.725 E05.318.740.998.825 E05.599.835.900 N05.715.360.750.530.650 N05.715.360.750.625.650 N05.715.360.750.695.650 N05.715.360.750.795.825 N06.850.520.830.500.700 N06.850.520.830.600.700 N06.850.520.830.750.725
|
| Concept/Terms |
Proportional Hazards Models- Proportional Hazards Models
- Proportional Hazard Models
- Hazard Model, Proportional
- Hazard Models, Proportional
- Model, Proportional Hazard
- Models, Proportional Hazard
- Proportional Hazard Model
- Models, Proportional Hazards
- Hazards Model, Proportional
- Hazards Models, Proportional
- Model, Proportional Hazards
- Proportional Hazards Model
Hazards Models- Hazards Models
- Hazards Model
- Model, Hazards
- Models, Hazards
- Hazard Models
- Hazard Model
- Model, Hazard
- Models, Hazard
|
Below are MeSH descriptors whose meaning is more general than "Proportional Hazards Models".
Below are MeSH descriptors whose meaning is more specific than "Proportional Hazards Models".
This graph shows the total number of publications written about "Proportional Hazards Models" by people in this website by year, and whether "Proportional Hazards Models" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 | | 2010 | 0 | 4 | 4 | | 2011 | 0 | 2 | 2 | | 2012 | 0 | 1 | 1 | | 2013 | 0 | 3 | 3 | | 2014 | 0 | 3 | 3 | | 2015 | 0 | 4 | 4 | | 2016 | 0 | 5 | 5 | | 2017 | 0 | 5 | 5 | | 2018 | 0 | 1 | 1 | | 2020 | 0 | 3 | 3 | | 2021 | 0 | 1 | 1 | | 2022 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Proportional Hazards Models" by people in Profiles.
-
Buras AL, Wang T, Whiting J, Townsend MK, Fridley BL, Tworoger SS. Prospective Analyses of Sedentary Behavior in Relation to Risk of Ovarian Cancer. Am J Epidemiol. 2022 05 20; 191(6):1021-1029.
-
Narayanan P, Man TK, Gerbing RB, Ries R, Stevens AM, Wang YC, Long X, Gamis AS, Cooper T, Meshinchi S, Alonzo TA, Redell MS. Aberrantly low STAT3 and STAT5 responses are associated with poor outcome and an inflammatory gene expression signature in pediatric acute myeloid leukemia. Clin Transl Oncol. 2021 Oct; 23(10):2141-2154.
-
Brown DD, Roem J, Ng DK, Reidy KJ, Kumar J, Abramowitz MK, Mak RH, Furth SL, Schwartz GJ, Warady BA, Kaskel FJ, Melamed ML. Low Serum Bicarbonate and CKD Progression in Children. Clin J Am Soc Nephrol. 2020 06 08; 15(6):755-765.
-
Greenberg JH, Abraham AG, Xu Y, Schelling JR, Feldman HI, Sabbisetti VS, Gonzalez MC, Coca S, Schrauben SJ, Waikar SS, Ramachandran VS, Shlipak MG, Warady B, Kimmel PL, Bonventre JV, Denburg M, Parikh CR, Furth S. Plasma Biomarkers of Tubular Injury and Inflammation Are Associated with CKD Progression in Children. J Am Soc Nephrol. 2020 05; 31(5):1067-1077.
-
Jacobson MH, Liu M, Wu Y, Furth S, Warady B, Trachtman H, Trasande L. Oxidant stress and renal function among children with chronic kidney disease: a repeated measures study. Sci Rep. 2020 02 21; 10(1):3129.
-
Getz KD, Sung L, Ky B, Gerbing RB, Leger KJ, Leahy AB, Sack L, Woods WG, Alonzo T, Gamis A, Aplenc R. Occurrence of Treatment-Related Cardiotoxicity and Its Impact on Outcomes Among Children Treated in the AAML0531 Clinical Trial: A Report From the Children's Oncology Group. J Clin Oncol. 2019 01 01; 37(1):12-21.
-
Lawrence YR, Samueli B, Levitin R, Pail O, Spieler B, Pfeffer R, Goldstein J, Den RB, Symon Z. Do Prostate Cancer Patients With Markedly Elevated PSA Benefit From Radiation Therapy?: A Population-based Study. Am J Clin Oncol. 2017 Dec; 40(6):605-611.
-
Guest EM, Aplenc R, Sung L, Raimondi SC, Hirsch BA, Alonzo TA, Gerbing RB, Wang YJ, Kahwash SB, Heerema-McKenney A, Meshinchi S, Gamis AS. Gemtuzumab ozogamicin in infants with AML: results from the Children's Oncology Group trials AAML03P1 and AAML0531. Blood. 2017 08 17; 130(7):943-945.
-
Sethna CB, Meyers KEC, Mariani LH, Psoter KJ, Gadegbeku CA, Gibson KL, Srivastava T, Kretzler M, Brady TM. Blood Pressure and Visit-to-Visit Blood Pressure Variability Among Individuals With Primary Proteinuric Glomerulopathies. Hypertension. 2017 08; 70(2):315-323.
-
Vujkovic M, Attiyeh EF, Ries RE, Goodman EK, Ding Y, Kavcic M, Alonzo TA, Wang YC, Gerbing RB, Sung L, Hirsch B, Raimondi S, Gamis AS, Meshinchi S, Aplenc R. Genomic architecture and treatment outcome in pediatric acute myeloid leukemia: a Children's Oncology Group report. Blood. 2017 06 08; 129(23):3051-3058.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|